EXTRA RENAL ORIGIN

Clinical trials for EXTRA RENAL ORIGIN explained in plain language.

Never miss a new study

Get alerted when new EXTRA RENAL ORIGIN trials appear

Sign up with your email to follow new studies for EXTRA RENAL ORIGIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat ovarian cancers: immune therapy trial

Disease control Ongoing

This study is testing whether two immunotherapy drugs, nivolumab alone or combined with ipilimumab, can help control recurrent clear cell ovarian, fallopian tube, and related cancers. It will enroll 46 patients whose cancer has returned after standard chemotherapy. The main goal …

Matched conditions: EXTRA RENAL ORIGIN

Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

EXTRA RENAL ORIGIN

Get alerted when new EXTRA RENAL ORIGIN trials appear

New hope for Tough-to-Treat ovarian cancers: immune therapy trial